📖 Approx. 9 min
In the business succession and M&A of a medical corporation, the fundamental procedure required to legally transfer managerial control is the "replacement of general members (shain)." Unlike the transfer of shares in a joint-stock company (kabushiki kaisha), the voting rights and property rights in a medical corporation are frequently bifurcated depending on the corporate structure and whether the corporation issues ownership equity interests (mochibun). Any procedural errors can lead to unexpected tax liabilities or governance disputes. This article provides a detailed breakdown of the practical steps involved in changing members during medical practice successions, along with the hidden risks surrounding taxation, administrative licenses, and facility standards.
Definition of "Members" in a Medical Corporation and Fundamental Differences from Shareholders
Under Japan's Medical Care Act, a "member" (shain) does not refer to an employee in the general corporate sense, but rather to a constituent member of the "General Meeting of Members" (shain sokai), which serves as the supreme decision-making body of an incorporated medical association (shadan iryo hojin). In contrast to a joint-stock company, where voting power is proportional to the number of shares held, Article 46-3-2 of the Medical Care Act stipulates that "the voting rights and election rights of each member shall be equal," establishing the statutory principle of one vote per person regardless of the amount of capital contributed.
While this principle reflects the foundational non-profit ethos of medical corporations, it introduces serious governance risks during M&A and third-party successions. For instance, even an individual who holds an overwhelming majority of the capital contribution has only a single vote as a member. If nominal members—such as family members or employed physicians who lent their names—cast dissenting votes, the corporation faces the real hazard of corporate paralysis on critical resolutions.
| Item | Joint-Stock Company (Shareholder) | Medical Corporation (Member) |
|---|---|---|
| Voting Power Ratio | Proportional to shares held (fundamentally 1 vote per share) | Per-capita equality (statutory principle of 1 vote per member) |
| Supreme Decision-Making Body | General Meeting of Shareholders (authority to appoint/remove directors, etc.) | General Meeting of Members (authority to appoint/remove directors and auditors, etc.) |
| Connection to Property Rights | Shareholder status and share value are intrinsically inseparable | Member status and capital ownership interest are legally bifurcated |
| Transfer of Status | Transferred through share sale, gift, or inheritance | Admission and withdrawal procedures (cannot be directly sold or inherited) |
| Distribution of Surpluses | Permitted (within distributable profits) | Prohibited by Article 54 of the Medical Care Act |
Consequently, to seamlessly transfer corporate control of a medical corporation to a successor or acquirer, merely executing a sale or gift of equity interests is insufficient. One must systematically implement the admission and withdrawal procedures for members to secure a dependable majority (or two-thirds or more for charter amendments, dissolution, and other supermajority matters) in the General Meeting of Members.
Standard Practical Process for Business Succession and M&A Involving Member Changes
The replacement of members must be conducted in strict compliance with the statutory provisions of the Medical Care Act and the articles of incorporation (charter) of the medical corporation. The standard sequence of steps in medical business succession is as follows:
- Current Membership Due Diligence: Cross-reference the articles of incorporation, historical minutes of the General Meeting of Members, and member registries to legally verify who currently qualifies as a valid member. If there are nominee members or missing persons, their status must be resolved beforehand.
- Resolution for Admission of Successor/Acquiring Members (General Meeting of Members): Convene the existing General Meeting of Members to pass a resolution approving the admission of new members. Under standard corporate charters, admission requires approval by the General Meeting of Members.
- Resolution for the Election of Officers (Directors and Auditors): In a General Meeting of Members that includes the newly admitted members, resolve the appointment of directors nominated by the successor side and the resignation of incumbent directors.
- Selection of New Board President by the Board of Directors: Convene a Board of Directors meeting composed of newly elected directors to select the new President of the Board of Directors (Rijicho), who, as a general statutory requirement, must hold a medical or dental license.
- Submission and Approval of Resignation Notices for Departing Members: Receive formal resignation notices signed and sealed by the departing directors and existing members, and formalize their withdrawal at the General Meeting of Members.
- Commercial Registration and Administrative Filings: Register the change of the President of the Board of Directors with the Legal Affairs Bureau (within two weeks) and file reports on officer changes and medical administrator changes with the prefectural government and local public health center.
Allowing existing members to resign before new members are admitted creates the risk of falling below the statutory quorum for the General Meeting of Members or losing a voting majority, thereby making the appointment of new officers impossible. In practice, it is crucial to carefully orchestrate the minutes—either by executing new member admissions and prior member resignations consecutively on the same day during the same General Meeting of Members, or by utilizing conditional resolutions to ensure no gap in voting control occurs.
Member Replacement in Corporations with Equity Interests and Capital Gains/Gift Tax Risks
For "medical corporations with equity interests" (transitional medical corporations incorporated prior to the April 2007 revisions to the Medical Care Act), the most significant challenge is structuring the succession of equity interests concurrently with the replacement of members. While membership status itself carries no monetary value, equity interests accumulate significant net-asset-based economic value over years of operation.
Capital Gains Tax on Equity Interest Transfers
When a successor or acquirer purchases equity interests from the departing board president, the difference between the sale price and the acquisition cost is taxed as capital gains under separate self-assessment taxation at a flat rate of 20.315% (15% income tax, 5% local inhabitants tax, and 0.315% special reconstruction income tax). In clinics and hospitals with substantial retained earnings accumulated over decades, the valuation can easily reach hundreds of millions of yen, triggering substantial tax liabilities.
Deemed Gift Tax Risks from Low-Value or Gratuitous Transfers
If equity interests are transferred to a successor at an unreasonably low price or gifted without compensation in an effort to minimize taxes, the transaction falls under "deemed gift" provisions pursuant to Article 7 of the Inheritance Tax Act, exposing the transferee to steep gift tax liabilities. With gift tax rates reaching up to 55%, transferring equity interests without an objective fair market valuation is exceptionally hazardous.
Furthermore, if an individual transfers equity interests to a corporate entity at an undervalue, the individual seller risks being taxed on deemed capital gains (Article 59 of the Income Tax Act), while the receiving entity faces taxation on donated profits (gain on gift receipt)—a compounding double-tax penalty. An independent equity appraisal by a qualified tax accountant is vital.
Member Changes in Fund-Contributed Medical Corporations (Without Equity Interests): Fund Reimbursement and Deemed Gift Considerations
For medical corporations established after May 2007 or those that waived equity interests to transition into "medical corporations without equity interests," the "fund-contributed medical corporation" (kikin kyoshutsu-gata) structure is standard. Because these entities have no capital equity interests, capital gains tax risks associated with property rights generally do not arise; however, they present distinct operational issues.
Fund Reimbursement Requirements and Treatment of Retained Earnings
Contributed funds represent liabilities of the medical corporation. Pursuant to provisions such as Article 54-2 of the Medical Care Act, funds may only be returned upon a resolution of the General Meeting of Members if the net asset value exceeds the aggregate amount of the contributed fund and statutory replacement reserves. When returning funds to a retiring board president during succession, one must meticulously verify whether the corporation possesses sufficient reimbursement reserves (surplus) and will not breach the statutory net-asset threshold.
Mitigating Exposure to Article 66, Paragraph 4 of the Inheritance Tax Act (Deemed Gift Tax on the Corporation)
When transferring membership to non-relatives or conducting third-party M&A involving a corporation without equity interests, the most critical tax risk is Article 66, Paragraph 4 of the Inheritance Tax Act. Under this provision, if the tax authorities determine that a medical corporation with concentrated family control unfairly minimized inheritance or gift taxes through succession, "the medical corporation itself is deemed an individual, and a gift tax of up to 55% is levied directly upon the corporation."
To avoid this punitive levy, the corporation must strictly comply with structural anti-family-dominance criteria: the charter must stipulate that residual assets upon dissolution revert exclusively to national or local governments, and relatives must comprise no more than one-third of all members and directors.
Impact of Member Replacement on Administrative Licenses, Facility Standards, and Regional Healthcare Plans
Replacing members and subsequently changing the board president and clinic administrator is not merely an internal corporate restructuring; it directly affects public administrative licenses and health insurance billing status. Overlooking these aspects can cause critical disruptions, such as the temporary suspension of insured medical services or clawbacks of reimbursed healthcare claims.
- Retroactive Procedures for Health Insurance Facility Designation: When changing the managing physician (administrator) of a clinic alongside the board president, filings for notification of changes must be submitted to the public health center and the Regional Bureau of Health and Welfare. Because the corporate entity holding the license does not change, this is treated procedurally as an "alteration of registered details"; however, clerical errors can cause an inadvertent lapse in insurance coverage, preventing the clinic from billing social health insurance during the interim.
- Re-notification Requirements for Facility Standards (Shisetsu Kijun): Certain facility billing standards (e.g., enhanced function allowances, home care support clinics/hospitals, specialized clinical systems) mandate specific full-time physician quotas or years of experience. If the outgoing board president retires completely and the count of full-time physicians falls, the facility may fail to satisfy the standards and be forced to downgrade its fee schedule.
- Bed Successions and the Regional Medical Care Vision in Over-Bedded Areas: In member changes (transfers of control) involving hospitals or clinics with inpatient beds, close attention must be paid to deliberations within the Regional Medical Care Vision Coordinating Conferences. Even when executing an M&A where the licensee entity remains intact, plans to repurpose bed functions or reactivate dormant beds frequently encounter severe obstacles during preliminary consultations with prefectural medical councils.
- Enterprise Tax Exemption Status under the Local Tax Act: Qualified medical corporations benefit from business tax exemptions or reductions on revenues derived from social health insurance treatments. Extreme changes in officer compositions or poorly conceived charter amendments must be managed carefully so as not to call into question the non-profit status of the corporation.
Internal Corporate Bylaws, Charter Amendments, and Critical Verification Checklist
Below is a checklist of critical due diligence items designed to prevent post-succession disputes and tax challenges during membership changes. A thorough review in collaboration with specialized advisors is strongly recommended prior to closing.
Essential Verification Checklist for Member Replacements
- ✅ Continuity of Past Member Minutes: Verify that all admissions and withdrawals of members from incorporation (or past charter amendments) to the present were executed through lawful resolutions.
- ✅ Absence of Missing or Nominee Members: Confirm there are no unreachable nominee members on record (eliminating grounds for nullification or non-existence of resolutions due to failure to serve convocation notices).
- ✅ Provisions for Voluntary Withdrawal in the Charter: Review how the charter defines voluntary withdrawal beyond "expulsion" and "death," and verify the required voting majorities for admissions and resignations.
- ✅ Proof of Equity Title and Title-Transfer Requests: Ensure that along with the Equity Interest Purchase Agreement, the equity member ledger has been updated and a certificate under the corporate seal of the Board President has been issued.
- ✅ Compliance with the One-Third Relative Rule: For corporations without equity interests, confirm that no single family or relative group constitutes more than one-third of the total officers in the new slate.
- ✅ Prior Consent for Release of Personal Guarantees and Collateral: Secure written pre-approval from financing financial institutions regarding the release of the outgoing board president’s joint-and-several personal guarantees and the assumption of guarantees by the incoming president.
The replacement of members in a medical corporation is a highly technical field where the Civil Code, the Medical Care Act, corporate tax law, and inheritance tax law intersect. Allowing sufficient lead time and building an unassailable evidentiary paper trail is the only dependable safeguard against costly legal disputes in healthcare succession.
Successfully navigating member transfers, equity interest successions, and third-party clinic M&A requires comprehensive planning that addresses both legal workflows and tax exposures across different corporate models. Board presidents and medical facility owners navigating membership cleanup, charter revisions, or smooth management handovers are urged to seek guidance from medical practice succession specialists early in the process.
Consult M&A Medical for Healthcare Succession Support
M&A Medical is a specialized advisory firm dedicated exclusively to healthcare M&A and business succession. As an M&A Support Agency certified by the Small and Medium Enterprise Agency, we assist clinics and medical corporations facing succession hurdles—from corporate divestitures to strategic acquisitions—on a contingency-fee basis.
- Initial consultations and preliminary valuations are free of charge
- Zero upfront retainer or monthly fees (success-fee only)
- Strict confidentiality guaranteed (non-disclosure agreement executed prior to discussions)
- Full national coverage across all 47 prefectures and all medical specialties
Whether you wish to assess current market valuations, address the absence of a successor, or evaluate joining a hospital network, please contact us early in your planning phase.